scispace - formally typeset
C

Cornelius Faber

Researcher at University of Münster

Publications -  147
Citations -  3975

Cornelius Faber is an academic researcher from University of Münster. The author has contributed to research in topics: Medicine & Magnetic resonance imaging. The author has an hindex of 32, co-authored 130 publications receiving 3290 citations. Previous affiliations of Cornelius Faber include University of Bayreuth & Ludwig Maximilian University of Munich.

Papers
More filters
BookDOI

In vivo NMR Imaging

TL;DR: In this paper, a short introduction to the physical and technical basics of nuclear magnetic resonance is given, which describes the formation of the NMR signal from the generation of the magnetization to the detection in the spectrometer.
Journal ArticleDOI

A dataset comprising 141 magnetic resonance imaging scans of 98 extant sea urchin species

TL;DR: It is argued that publicly available digital anatomical and morphological data gathered during experiments involving non-invasive imaging techniques constitute one of the prerequisites for future large-scale genotype—phenotype correlations.
Journal ArticleDOI

A longitudinal PET/MR imaging study of colony stimulating factor-1 receptor-mediated microglia depletion in experimental stroke.

TL;DR: In this article, the effects of chronic colony stimulating factor-1 receptor (CSF-1R) inhibitor-mediated microglia depletion on translocator protein (TSPO)-dependent neuroinflammation and cerebrovascular parameters using positron emission tomography (PET)/magnetic resonance (MR) imaging were investigated.
Journal ArticleDOI

Defining mechanisms of neural plasticity after brainstem ischemia in rats.

TL;DR: Neurological recovery after stroke mainly depends on the location of the lesion, but patterns of neural plasticity following brainstem ischemia are almost unknown.
Journal ArticleDOI

Functionalization of Clinically Approved MRI Contrast Agents for the Delivery of VEGF

TL;DR: In combining the two clinically approved substances ferumoxytol and VEGF-165 via peptide coupling, this work proposes a straightforward approach to obtain a potentially ready-to-use theranostic contrast agent for specific cardiovascular diseases.